347 related articles for article (PubMed ID: 30309818)
41. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with Hematuria.
Oh TJ; Lee JY; Seo Y; Woo MA; Lim JS; Na YG; Song KH; Bang BR; Lee JJ; Shin JH; An S
J Mol Diagn; 2023 Sep; 25(9):646-654. PubMed ID: 37330048
[TBL] [Abstract][Full Text] [Related]
43. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
44. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
Piao XM; Jeong P; Kim YH; Byun YJ; Xu Y; Kang HW; Ha YS; Kim WT; Lee JY; Woo SH; Kwon TG; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
Int J Cancer; 2019 Jan; 144(2):380-388. PubMed ID: 30183088
[TBL] [Abstract][Full Text] [Related]
45. A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria.
Karnes RJ; Fernandez CA; Shuber AP
Mayo Clin Proc; 2012 Sep; 87(9):835-42. PubMed ID: 22883743
[TBL] [Abstract][Full Text] [Related]
46. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
[TBL] [Abstract][Full Text] [Related]
47. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
[TBL] [Abstract][Full Text] [Related]
48. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S
BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035
[TBL] [Abstract][Full Text] [Related]
49. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
50. Urinary mRNA biomarker panel for the detection of urothelial carcinoma.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851
[TBL] [Abstract][Full Text] [Related]
51. Novel urinary biomarkers for the detection of bladder cancer: A systematic review.
Tan WS; Tan WP; Tan MY; Khetrapal P; Dong L; deWinter P; Feber A; Kelly JD
Cancer Treat Rev; 2018 Sep; 69():39-52. PubMed ID: 29902678
[TBL] [Abstract][Full Text] [Related]
52. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
[TBL] [Abstract][Full Text] [Related]
53. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
[TBL] [Abstract][Full Text] [Related]
54. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ
J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367
[TBL] [Abstract][Full Text] [Related]
55. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.
Kavalieris L; O'Sullivan PJ; Suttie JM; Pownall BK; Gilling PJ; Chemasle C; Darling DG
BMC Urol; 2015 Mar; 15():23. PubMed ID: 25888331
[TBL] [Abstract][Full Text] [Related]
56. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
57. Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer.
Luo ZG; Li ZG; Gui SL; Chi BJ; Ma JG
J Int Med Res; 2014 Feb; 42(1):35-41. PubMed ID: 24366498
[TBL] [Abstract][Full Text] [Related]
58. Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.
Chen PC; Tsai MH; Yip SK; Jou YC; Ng CF; Chen Y; Wang X; Huang W; Tung CL; Chen GC; Huang MM; Tong JH; Song EJ; Chang DC; Hsu CD; To KF; Shen CH; Chan MW
BMC Med Genomics; 2011 May; 4():45. PubMed ID: 21599969
[TBL] [Abstract][Full Text] [Related]
59. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
[TBL] [Abstract][Full Text] [Related]
60. A multiplex immunoassay for the non-invasive detection of bladder cancer.
Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ
J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
